Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety
MT Mascellino, F Di Timoteo… - Infection and drug …, 2021 - Taylor & Francis
… The anti-CoV-2 vaccines were developed in a much shorter time than previous vaccines: …
used in humans, whereas the anti-SARS-CoV-2 vaccines were ready in eight to ten months. …
used in humans, whereas the anti-SARS-CoV-2 vaccines were ready in eight to ten months. …
Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), known to cause the
disease COVID-19, was declared a pandemic in early 2020. The objective of this review was …
disease COVID-19, was declared a pandemic in early 2020. The objective of this review was …
Anti-SARS-CoV-2 potential of artemisinins in vitro
R Cao, H Hu, Y Li, X Wang, M Xu, J Liu… - ACS Infectious …, 2020 - ACS Publications
… We systematically evaluated the anti-SARS-CoV-2 activities of … Arteannuin B showed the
highest anti-SARS-CoV-2 potential … step of SARS-CoV-2 infection. This research highlights the …
highest anti-SARS-CoV-2 potential … step of SARS-CoV-2 infection. This research highlights the …
[HTML][HTML] WHO International Standard for anti-SARS-CoV-2 immunoglobulin
PA Kristiansen, M Page, V Bernasconi… - Lancet (London …, 2021 - ncbi.nlm.nih.gov
… scientific community with a research reagent for an anti-SARS-CoV-2 antibody. The availability
of … for the WHO International Standards for anti-SARS-CoV-2 immunoglobulin. The study …
of … for the WHO International Standards for anti-SARS-CoV-2 immunoglobulin. The study …
Evolution of anti-SARS-CoV-2 therapeutic antibodies
JC Almagro, G Mellado-Sánchez… - International journal of …, 2022 - mdpi.com
… We [96] and other authors [97] have shown that IgG1 predominates the anti-SARS-CoV-2
immune … when ADCC and CDC are wanted, as in the therapeutic anti-SARS-CoV-2 antibodies. …
immune … when ADCC and CDC are wanted, as in the therapeutic anti-SARS-CoV-2 antibodies. …
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
… a The total anti-SARS-CoV-2 IgM and IgG level of confirmed … c The prevalence of total
anti-SARS-CoV-2 IgM and IgG. The X … The increase of anti-SARS-CoV-2 antibody levels is one of …
anti-SARS-CoV-2 IgM and IgG. The X … The increase of anti-SARS-CoV-2 antibody levels is one of …
Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation
V Higgins, A Fabros, V Kulasingam - Journal of clinical …, 2021 - Am Soc Microbiol
… of qualitative anti-SARS-CoV-2 serology assays, including the qualitative Roche anti-SARS-CoV-2 …
No samples that were positive by the qualitative Roche anti-SARS-CoV-2 assay were …
No samples that were positive by the qualitative Roche anti-SARS-CoV-2 assay were …
[HTML][HTML] Performance evaluation of the Roche Elecsys anti-SARS-CoV-2 S immunoassay
E Riester, P Findeisen, JK Hegel, M Kabesch… - Journal of virological …, 2021 - Elsevier
… that the Elecsys Anti-SARS-CoV-2 S assay can be utilized to meet the current need for
anti-SARS-CoV-2 antibody testing, alongside or in place of the Elecsys Anti-SARS-CoV-2 (N) …
anti-SARS-CoV-2 antibody testing, alongside or in place of the Elecsys Anti-SARS-CoV-2 (N) …
[PDF][PDF] Elecsys Anti-SARS-CoV-2
R Diagnostics - US FAD-EUA, 2020 - rrvbc.org
(COVID-19) result that is incorrect (false negative) in some people with COVID-19. A negative
result may occur if you are tested during the early stages of your illness where your body …
result may occur if you are tested during the early stages of your illness where your body …
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro
… anti-SARS-CoV-2 M pro potential have been recommended as rapid and effective alternative
for anti-SARS-CoV… natural compounds were identified against SARS-CoV-2 M pro from NP-…
for anti-SARS-CoV… natural compounds were identified against SARS-CoV-2 M pro from NP-…